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DNA polymerase ß (Polß) is recognized
as an essential DNA repair protein [1,2].
Although the smallest of the human DNA
polymerases [3,4], this 335–amino-acid
protein is the primary DNA polymerase
in the base excision repair (BER) pathway
[5]. A majority of the 20,000 DNA lesions
per day that each human cell is faced with
are repaired by the BER pathway [6].
These include products of base depurina-
tion and depyrimidination (abasic sites),
deamination of cytosine and 5-methylcyt-
osine, oxidation products such as 8-oxo-
7,8-dihydro-29-deoxyguanosine (8-oxodG),
thymine glycol and lipid peroxidation
products, as well as methylation modifica-
tions such as N7-guanine [7,8]. Failure to
repair these spontaneous or endogenously
induced DNA base lesions as well as the
numerous base modifications that arise
from environmental or exogenous sources
can result in multiple cellular effects,
including cell death, gene mutations, gene
rearrangements, and/or decreased cell
growth rate. Polß facilitates the repair of
these base lesions in concert with different
proteins of the BER pathway depending on
the lesion [2,7]. Once the base lesion is
removed by one of 11 DNA glycosylase
enzymes and the resulting abasic site is
hydrolysed by the endonuclease APE1,
Polß is recruited to the lesion via an
interaction with the BER scaffold protein
XRCC1 [9,10] and the DNA damage
sensor PARP1 [11–13]. Polß then conducts
two essential enzymatic functions: 59dRP
lyase–mediated gap tailoring and DNA
polymerase–mediated DNA synthesis to fill
the gap [2,3]. The 59dRP lyase activity
functions to ‘‘tailor’’ the gap by removing
the sugar-phosphate residue that remains
after APE1 cleaves the DNA backbone,
and then the polymerase activity adds the
newly synthesized nucleotide that was
removed during repair. Considering the
critical and essential role of these two
enzymatic activities, the important pro-
tein–protein interactions between Polß and
several BER proteins [14], as well as the
increasing number of post-translational
modifications suggested to affect Polß
function and stability [15], it may not be
surprising that a significant number of
somatic mutations in POLB have been
observed in cancer (Table 1). Within the
33 Kb POLB gene (PubMed geneID
#5423), as many as 567 SNPs have been
identified (see dbSNP). However, only 34
SNPs are in or near the coding region (22
are found in exons), and only two have
been confirmed in larger cohorts. These
two germline POLB mutants (R137Q;
rs12678588 and P242R; rs3136797) have
been reported to be present in as much as
0.6% and 2.4% of the human population,
respectively [16,17]. However, little is
known about the functional impact that
results from these single amino acid alter-
ations. An earlier study on the Polß
(R137Q) mutant (rs12678588) suggested
that the R137Q mutation impairs function
of the purified protein. Further, when
produced in mouse cells, the R137Q
mutant protein interfered with Polß bind-
ing to PCNA [18] and the response of
mouse cells to DNA-damaging agents,
although no information was provided on
the impact of this mutation on genome
stability. Whereas the Polß (P242R) mutant
allele (rs3136797) has been linked with
altered incidence of cancer in several
studies [19–21], there have been few or
no studies defining the impact of this SNP
on Polß function, DNA repair capacity,
and genome maintenance in human cells.
In this issue of PLOS Genetics, Sweasy
and colleagues conducted a detailed anal-
ysis of the POLB germline–coding SNP
rs3136797 [22]. This polymorphism alters
amino acid 242, changing the amino acid
from a proline (P; Pro) to an arginine (R;
Arg). To determine whether the P242R
mutation affected genome stability in
human or mouse cells, the wild-type
(WT) or P242R protein was produced in
human normal mammary epithelial cells
(MCF10A) and in mouse embryonic
fibroblasts (MEFs). In both cell lines, the
synthesis of the P242R protein led to an
increase in genomic alterations. Analysis of
metaphase spreads showed that the P242R
protein induced an increase in chromo-
some breaks and a significant increase in
fragmented chromosomes and chromo-
some fusions. In other reports, cancer-
specific mutations in Polß (e.g., Y265C)
induced an increase in mutant frequency
[23,24] that could explain the increase in
chromosome alterations seen with P242R.
However, cells producing the P242R
protein were found to have the same
mutant frequency as those expressing WT
Polß. The lack of an increase in mutations
together with the increase in chromosomal
instability suggested that the Polß (P242R)
protein may promote the accumulation of
DNA strand breaks during repair. To test
this hypothesis, the cells were treated with
methyl methanesulfonate (MMS) to in-
duce DNA damage repaired by Polß [5].
As suspected, exposure of the cells ex-
pressing the P242R mutant to MMS
induced a greater level of single-strand
and double-strand DNA breaks. The
increase in single-strand breaks and relat-
ed BER intermediates was measured by
the alkaline Comet assay [25], and an
increase in the number of DNA double-
strand breaks was indirectly determined by
measuring an increase in c-H2AX foci
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Table 1. Germline and somatic POLB mutants.*
WT Residue Residue Number Mutant Residue Polß Domain
Functional or Correlative Effect of
Mutation Citation
Gln 8 Arg 8K n.d. [17]
Leu 22 Pro 8K Loss of 59dRP lyase activity [37]
Leu 22 Pro 8K Suppressed BER activity [38]
Lys 27 Asn 8K Decreased catalytic (59dRP lyase) activity [39]
Tyr 39 Cys 8K n.d. [38]
Gly 80 Arg 8K n.d. [40]
Ile 88 Val 8K n.d. [41,42]
Phe 114 Ser Fingers n.d. [41]
Gly 118 Glu Fingers n.d. [41]
Glu 123 Lys Fingers Decreased catalytic (polymerase) activity [39]
Arg 137 Gln Fingers Decreased interaction with PCNA,
reduced polymerase activity
[18]
Arg 137 Gln Fingers n.d. [17]
Arg 137 Gln Fingers Haplotype analysis [16]
Asp 160 Asn Palm n.d. [38]
Asp 160 Asn Palm Increase in cellular transformation [27]
Lys 167 Ile Palm n.d. [41]
Gly 179 Arg Palm n.d. [41]
Arg 182 Gly Palm n.d. [43]
Arg 183 Gly Palm n.d. [41]
Glu 186 Gly Palm n.d. [41,42]
Glu 216 Lys Palm No observed change in activity [39]
Gly 231 Asp Palm Decreased catalytic rate and decreased
binding affinity of nucleotides
[44]
Glu 232 Lys Palm Decreased catalytic (polymerase) activity [39]
Met 236 Leu Palm Decreased catalytic (polymerase) activity [39]
Cys 239 Arg Palm n.d. [38]
Pro 242 Arg Palm n.d. [17,45]
Pro 242 Arg Palm Decreased catalytic (polymerase) activity [39]
Pro 242 Arg Palm Haplotype analysis [16]
Pro 242 Arg Palm Decreased risk of colorectal cancer [19]
Pro 242 Arg Palm Increase in cellular transformation and
genome instability
[22]
Ile 260 Met Palm Misalignment-mediated errors in
dipyrimidine sequences
[46]
Ile 260 Met Palm Increase in cellular transformation [28]
Tyr 265 Cys Thumb Increase in mutation frequency [23,24]
Tyr 265 Cys Thumb Increase in BER intermediates, chromosome
aberrations, and DNA breaks
[47]
Asn 281 Ser Thumb n.d. [40]
Glu 288 Lys Thumb Increase in mutations at A/T base pairs [48]
Lys 289 Met Thumb Increase in mutation frequency [49]
Lys 289 Met Thumb n.d. [45,50]
Lys 289 Met Thumb Increase in cellular transformation [28]
Asn 294 Asp Thumb n.d. [38]
Glu 295 Lys Thumb Decreased polymerase activity, acts
as a dominant negative
[51]
Glu 295 Lys Thumb Loss of BER and DNA polymerase activity [38]
Glu 295 Lys Thumb Decreased polymerase activity that may
stem from steric interaction with Arg258
[52]
n.d.=not determined.
*See [53] for an extensive list of POLB gene mutations recently identified in colorectal tumors.
doi:10.1371/journal.pgen.1003086.t001
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[26]. A second phenotype that Sweasy and
colleagues have linked with cancer mu-
tants of Polß is the ability to induce
cellular transformation, as was seen with
the D160N, I260M, and K289M Polß
mutants [27,28]. Similarly, production of
the P242R mutant protein in mouse cells
(C127l) or human cells (MCF10A) in-
creased growth in soft agar significantly in
comparison with expression of WT Polß.
Yamtich et al. [22] then used both
cellular analysis and biochemical measure-
ments to evaluate the functional impact of
the P242R mutation. WT MEF cells
(expressing endogenous WT Polß) were
engineered to produce either WT human
Polß or the P242R mutant protein and
were then exposed to MMS to measure
cellular survival. Both WT- and P242R-
expressing cells responded equally except
at the highest doses of MMS. Next, Polß-
knock out (KO) MEFs engineered to
express either WT human Polß or the
P242R mutant were exposed to MMS to
determine whether the P242R mutant
could restore (complement) resistance to
MMS. In this case, there was a small but
significant difference in response, suggest-
ing that the P242R mutant was mildly
defective in BER. A strength of the Sweasy
Figure 1. Model depicting the structure of Polß. (A) Structure (pdb2fms) depicting DNA Polymerase ß (Polß) with a gapped DNA substrate and
dUMPNPP with magnesium in the catalytic site [35]. The image is a cartoon rendition of the polypeptide chain of Polß in teal, the gapped DNA
substrate in salmon, and the incoming dUMPNPP base in green. Amino acids known to be altered by germline mutations are shown using a space-
filling rendering: R137 (magenta) and P242 (orange). The fingers, palm, and thumb domains of Polß are indicated. The 8K domain is at the back of the
structure, facing away from the plane of the image, and is shown behind the DNA in this orientation. (B) Structure (pdb3lqc) depicting oxidized
XRCC1 bound to the Polß palm/thumb domains [36]. The image is a cartoon rendition of the palm and thumb domains of Polß in blue, with a mesh
illustrating the surface of the structure (amino acids 150–335), and a cartoon rendition of the oxidized form of XRCC1 in green, with a mesh
illustrating the surface of the structure (amino acids 1–151). Amino acid P242 (orange) is shown using a space-filling rendering. The images were
generated using PyMOL (Molecular Graphics System, Version 1.2r3pre; Schro¨dinger, LLC; http://pymol.org/).
doi:10.1371/journal.pgen.1003086.g001
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lab’s study is the use of cell biology
analyses as well as detailed biochemical
evaluation of these mutant proteins. Yam-
tich et al. [22] expressed and purified the
WT and P242R mutant proteins from E.
coli and measured the rate of DNA
polymerase activity by two separate kinetic
analyses. This provided the opportunity to
determine whether the decreased BER
capacity observed in the Polß-KO MEFs
expressing the P242R mutant in response
to MMS and the increase in DNA breaks
were the result of a defect in the poly-
merase activity of the P242R mutant. In
both cases, they found that the mutation
(P242R) caused a decrease in the rate of
DNA polymerase activity. However, the
protein bound to the DNA substrate with
affinity equal to that of the WT enzyme.
The slow polymerase activity of the P242R
protein therefore is likely to promote the
accumulation of BER intermediates, in-
ducing genome alterations when the cell is
exposed to DNA-damaging agents [29].
Defects in Polß can have significant cel-
lular ramifications, especially in response
to DNA-damaging agents that require
Polß and BER for repair. Complete loss
of Polß function can trigger an increase
in cell death in response to high doses
of genotoxins [5,30] and an increase in
genome alterations even at low doses [29].
Additional cellular responses to DNA
damage when Polß is defective may
include PARP1 activation and alterations
in bioenergetic metabolites such as NAD+
[31]. The steady-state expression level of
Polß is also reported to be regulated by the
proteasome via ubiquitylation [32], sug-
gesting that some Polß mutants may have
altered stability. In this regard, the obser-
vation that the P242R mutant protein has
a functional defect now opens the door for
further studies to clarify the mechanisms
and cellular impacts of other defects in
Polß. It has been suggested that tumor-
specific defects in BER, such as a defect in
Polß, may be exploited for selective
therapeutic options [33]. Cells producing
the mutant protein (P242R) have a higher
level of DNA strand breaks and increased
cellular transformation, and so it is
possible that the Polß (P242R) protein
may be considered a driver of cancer
formation. It remains to be determined
whether the presence of this mutant
protein (P242R) provides therapeutic se-
lectivity.
Finally, it remains to be determined how
a mutation (P242R) so distant from the
Polß active site, and which does not inter-
fere with binding to XRCC1 (Figure 1),
can have such a significant effect on the
function of Polß. Given the subtle yet
significant impact of the Polß (P242R)
mutant on cellular function and genome
stability in response to DNA damage as
described by Yamtich et al [22], further
analysis of this mutant protein is warranted.
The P242 amino acid is located in a loop
domain that is essential for enzymatic
activity [34], so it is likely that the alteration
of the amino acid from P to R changes the
movement of the loop and may also change
the overall architecture of the protein. To
more completely appreciate the subtle yet
significant defect associated with this germ-
line mutation, it is therefore suggested that
future studies be conducted to determine
the structure of the ternary complex of Polß
(P242R) with DNA and an incoming
nucleotide. In addition, whole animal
studies should be considered so as to
determine whether the genome instability
and cellular transformation results de-
scribed [22] extend to additional cell types.
As a germline mutation, analysis of the
P242R mutant protein in an animal model
will provide valuable insight into the
possible effects on human health.
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